The effects of IL-6 and IL-10 and their specific antibodies in the acute inflammatory responses induced by carrageenan in the mouse model of pleurisy

Cytokine

Volumn 17, Issue 3, 2002, Pages 149-156

  Fröde, Tânia S ^a   Souza, Glória E P ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti inflammatory cytokines; Carrageenan; Mice; Pleural inflammation

Indexed keywords

CARRAGEENAN; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE MIGRATION INHIBITION; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURISY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGY; MALE;

ANIMALS; CARRAGEENAN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE; PLEURISY;

EID: 0035988178     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0980     Document Type: Article

References (39)

1. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
2. The role of interleukin-10 in the pathogenesis of bacterial infection
3. Genetic influence on cytokine production and fatal meningococcal disease
4. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
5. IL-6 as a drug discovery target
6. IL-6: Insights into novel biological activities
7. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model
8. Anti-inflammatory cytokines
9. Response of interleukin-6 deficient mice to tumor necrosis factor-induced metabolic changes and lethality
10. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
11. Characterization of early cytokine responses and an interleukin-6 dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection
12. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necorsis factor receptor p55
13. Biological properties of interleukin 10
14. Interleukin-10: Potential benefits and possible risks in clinical infectious diseases
15. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
16. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia
17. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity
18. Interleukin 10 inhibits TNF-alpha production in human monocytes independently of interleukin 12 and interleukin 1 beta
19. Net inflammatory capacity of human septic shock plasma evaluated by monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
20. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF-kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokines synthesis by different mechanisms
21. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
22. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes
23. Interleukin-10-deficient mice develop chronic enterocolitis
24. Interleukin-10: An anti-inflammatory cytokine with therapeutic potential
25. Interleukin-10 biology, role in inflammation and autoimmunity
26. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse
27. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy
28. Interlukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice
29. Modulation by IL-10 of antigen-induced allergic responses in mice
30. Endogenous IL-10 protects mice from death during septic peritonitis
31. Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interelukin-1 beta, and interleukin-6 in mouse alveola macrophages
32. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10
33. IL-10 inhibits cytokine production by activated macrophages
34. Interleukin 10 inhibits cell inflammatory infiltration in endotoxin-induced uveitis
35. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia
36. IL-10 down-regulates human microglial IL-6 by inhibition of NF-κB activation
37. Sequential appearance of IL-1 and IL-6 activities in rat carrageenan-induced pleurisy
38. Ethical guidelines for investigations of experimental pain in conscious animals
39. The modulatory role played by TNFα and IL1β in the inflammatory responses induced by carrageenan in the mouse model of pleurisy